Inhaled Nitric Oxide Delivery Systems Market Size, Share & Trends Analysis Report By Type (Pediatric, Adult), By Application (HRF, AHRF), By Product (Disposables, Systems), By End Use- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2021-2027
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Product Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Inhaled Nitric Oxide Delivery Systems Market, By Type
7.1. Inhaled Nitric Oxide Delivery Systems Market, by Type, 2021-2027
7.1.1. Pediatrics
7.1.1.1. Market Revenue and Forecast (2017-2027)
7.1.2. Adult
7.1.2.1. Market Revenue and Forecast (2017-2027)
Chapter 8. Global Inhaled Nitric Oxide Delivery Systems Market, By Application
8.1. Inhaled Nitric Oxide Delivery Systems Market, by Application, 2021-2027
8.1.1. Hypoxic Respiratory Failure (HRF)
8.1.1.1. Market Revenue and Forecast (2017-2027)
8.1.2. Acute Hypoxemic Respiratory Failure (AHRF)
8.1.2.1. Market Revenue and Forecast (2017-2027)
8.1.3. Others
8.1.3.1. Market Revenue and Forecast (2017-2027)
Chapter 9. Global Inhaled Nitric Oxide Delivery Systems Market, By Product
9.1. Inhaled Nitric Oxide Delivery Systems Market, by Product, 2021-2027
9.1.1. Disposables
9.1.1.1. Market Revenue and Forecast (2017-2027)
9.1.2. System
9.1.2.1. Market Revenue and Forecast (2017-2027)
Chapter 10. Global Inhaled Nitric Oxide Delivery Systems Market, By End-user
10.1. Inhaled Nitric Oxide Delivery Systems Market, by End-user, 2021-2027
10.1.1. Hospitals
10.1.1.1. Market Revenue and Forecast (2017-2027)
10.1.2. Ambulatory Centers
10.1.2.1. Market Revenue and Forecast (2017-2027)
10.1.3. Clinics
10.1.3.1. Market Revenue and Forecast (2017-2027)
Chapter 11. Global Inhaled Nitric Oxide Delivery Systems Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Type (2017-2027)
11.1.2. Market Revenue and Forecast, by Application (2017-2027)
11.1.3. Market Revenue and Forecast, by Product (2017-2027)
11.1.4. Market Revenue and Forecast, by End-user (2017-2027)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, by Type (2017-2027)
11.1.5.2. Market Revenue and Forecast, by Application (2017-2027)
11.1.5.3. Market Revenue and Forecast, by Product (2017-2027)
11.1.5.4. Market Revenue and Forecast, by End-user (2017-2027)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, by Type (2017-2027)
11.1.6.2. Market Revenue and Forecast, by Application (2017-2027)
11.1.6.3. Market Revenue and Forecast, by Product (2017-2027)
11.1.6.4. Market Revenue and Forecast, by End-user (2017-2027)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Type (2017-2027)
11.2.2. Market Revenue and Forecast, by Application (2017-2027)
11.2.3. Market Revenue and Forecast, by Product (2017-2027)
11.2.4. Market Revenue and Forecast, by End-user (2017-2027)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, by Type (2017-2027)
11.2.5.2. Market Revenue and Forecast, by Application (2017-2027)
11.2.5.3. Market Revenue and Forecast, by Product (2017-2027)
11.2.5.4. Market Revenue and Forecast, by End-user (2017-2027)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, by Type (2017-2027)
11.2.6.2. Market Revenue and Forecast, by Application (2017-2027)
11.2.6.3. Market Revenue and Forecast, by Product (2017-2027)
11.2.6.4. Market Revenue and Forecast, by End-user (2017-2027)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, by Type (2017-2027)
11.2.7.2. Market Revenue and Forecast, by Application (2017-2027)
11.2.7.3. Market Revenue and Forecast, by Product (2017-2027)
11.2.7.4. Market Revenue and Forecast, by End-user (2017-2027)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, by Type (2017-2027)
11.2.8.2. Market Revenue and Forecast, by Application (2017-2027)
11.2.8.3. Market Revenue and Forecast, by Product (2017-2027)
11.2.8.4. Market Revenue and Forecast, by End-user (2017-2027)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Type (2017-2027)
11.3.2. Market Revenue and Forecast, by Application (2017-2027)
11.3.3. Market Revenue and Forecast, by Product (2017-2027)
11.3.4. Market Revenue and Forecast, by End-user (2017-2027)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, by Type (2017-2027)
11.3.5.2. Market Revenue and Forecast, by Application (2017-2027)
11.3.5.3. Market Revenue and Forecast, by Product (2017-2027)
11.3.5.4. Market Revenue and Forecast, by End-user (2017-2027)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, by Type (2017-2027)
11.3.6.2. Market Revenue and Forecast, by Application (2017-2027)
11.3.6.3. Market Revenue and Forecast, by Product (2017-2027)
11.3.6.4. Market Revenue and Forecast, by End-user (2017-2027)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, by Type (2017-2027)
11.3.7.2. Market Revenue and Forecast, by Application (2017-2027)
11.3.7.3. Market Revenue and Forecast, by Product (2017-2027)
11.3.7.4. Market Revenue and Forecast, by End-user (2017-2027)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, by Type (2017-2027)
11.3.8.2. Market Revenue and Forecast, by Application (2017-2027)
11.3.8.3. Market Revenue and Forecast, by Product (2017-2027)
11.3.8.4. Market Revenue and Forecast, by End-user (2017-2027)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Type (2017-2027)
11.4.2. Market Revenue and Forecast, by Application (2017-2027)
11.4.3. Market Revenue and Forecast, by Product (2017-2027)
11.4.4. Market Revenue and Forecast, by End-user (2017-2027)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, by Type (2017-2027)
11.4.5.2. Market Revenue and Forecast, by Application (2017-2027)
11.4.5.3. Market Revenue and Forecast, by Product (2017-2027)
11.4.5.4. Market Revenue and Forecast, by End-user (2017-2027)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, by Type (2017-2027)
11.4.6.2. Market Revenue and Forecast, by Application (2017-2027)
11.4.6.3. Market Revenue and Forecast, by Product (2017-2027)
11.4.6.4. Market Revenue and Forecast, by End-user (2017-2027)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, by Type (2017-2027)
11.4.7.2. Market Revenue and Forecast, by Application (2017-2027)
11.4.7.3. Market Revenue and Forecast, by Product (2017-2027)
11.4.7.4. Market Revenue and Forecast, by End-user (2017-2027)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, by Type (2017-2027)
11.4.8.2. Market Revenue and Forecast, by Application (2017-2027)
11.4.8.3. Market Revenue and Forecast, by Product (2017-2027)
11.4.8.4. Market Revenue and Forecast, by End-user (2017-2027)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Type (2017-2027)
11.5.2. Market Revenue and Forecast, by Application (2017-2027)
11.5.3. Market Revenue and Forecast, by Product (2017-2027)
11.5.4. Market Revenue and Forecast, by End-user (2017-2027)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, by Type (2017-2027)
11.5.5.2. Market Revenue and Forecast, by Application (2017-2027)
11.5.5.3. Market Revenue and Forecast, by Product (2017-2027)
11.5.5.4. Market Revenue and Forecast, by End-user (2017-2027)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, by Type (2017-2027)
11.5.6.2. Market Revenue and Forecast, by Application (2017-2027)
11.5.6.3. Market Revenue and Forecast, by Product (2017-2027)
11.5.6.4. Market Revenue and Forecast, by End-user (2017-2027)
Chapter 12. Company Profiles
12.1. Mallinckrodt Pharmaceuticals
12.1.1. Company Overview
12.1.2. Type Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Getinge
12.2.1. Company Overview
12.2.2. Type Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Vero Biotech
12.3.1. Company Overview
12.3.2. Type Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. LINDE
12.4.1. Company Overview
12.4.2. Type Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Beyond Air
12.5.1. Company Overview
12.5.2. Type Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. SLE
12.6.1. Company Overview
12.6.2. Type Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. NU MED
12.7.1. Company Overview
12.7.2. Type Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Bellerophon Therapeutics
12.8.1. Company Overview
12.8.2. Type Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Air Liquide Healthcare
12.9.1. Company Overview
12.9.2. Type Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Circassia Pharmaceuticals
12.10.1. Company Overview
12.10.2. Type Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
Glossary of Terms